Metropolis Healthcare shares are trading lower on higher volumes. Credit Suisse noted that the company’s stock is expensive despite correction. The company reported a 30% YoY fall in Q3 net profit reported on February 11.
Metropolis Healthcare Limited is an India-based diagnostics company that operates through the pathology services segment. The Company offers a range of clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and monitoring of the disease. The Company also offers analytical and support services to clinical research organizations for their clinical research projects. Its services include pathology testing services, corporate wellness, lab in hospitals and clinical research services. The Company offers a range of tests and profiles that include advanced tests in diagnosis of cancer, neurological disorders, infectious diseases, and an array of genetic abnormalities. It owns a chain of diagnostic centers across India, South Asia, Africa and the Middle East. The Company has spread its footprint across 20 Indian states and over 210 cities.
View Price, OI, Greeks and more...
| Day | Open | Close | Day's change |
|---|---|---|---|
| Fri, May 26 | 1,262.80 | 1,284.80 | 1.71% |
| Thu, May 25 | 1,260.05 | 1,253.95 | -0.49% |
| Wed, May 24 | 1,259.00 | 1,261.35 | 0.19% |
| Tue, May 23 | 1,245.90 | 1,259.00 | 1.04% |
| Mon, May 22 | 1,229.05 | 1,242.50 | 1.08% |
| Fri, May 19 | 1,251.25 | 1,224.50 | -2.18% |
| Thu, May 18 | 1,298.00 | 1,241.30 | -4.57% |
On Mutual Fund and IPOs
On Equity Delivery orders
On Equity Intraday, F&O, Commodity and Currency orders
On Mutual Fund and IPOs
On Equity Delivery orders
On Equity Intraday, F&O, Commodity and Currency orders
Healthcare Services 
